Should we use standard survival models or the illness-death model for interval-censored data to investigate risk factors of chronic kidney disease progression? gan Julie Boucquemont, Marie Metzger, Christian Combe, Bénédicte Stengel, Karen Leffondre, NephroTest Study Group

Cael y testun llawn

A 3-marker index improves the identification of iron disorders in CKD anaemia. gan Lucile Mercadal, Marie Metzger, Jean Philippe Haymann, Eric Thervet, Jean-Jacques Boffa, Martin Flamant, François Vrtovsnik, Cédric Gauci, Marc Froissart, Bénédicte Stengel, NephroTest Study Group

Cael y testun llawn

Low Serum Creatine Kinase Level Predicts Mortality in Patients with a Chronic Kidney Disease. gan Adrien Flahault, Marie Metzger, Jean-François Chassé, Jean-Philippe Haymann, Jean-Jacques Boffa, Martin Flamant, François Vrtovsnik, Pascal Houillier, Bénédicte Stengel, Eric Thervet, Nicolas Pallet, NephroTest study group

Cael y testun llawn

Correction to: Association of plasma potassium with mortality and end-stage kidney disease in patients with chronic kidney disease under nephrologist care - The NephroTest study gan Sandra Wagner, Marie Metzger, Martin Flamant, Pascal Houillier, Jean-Philippe Haymann, François Vrtovsnik, Eric Thervet, Jean-Jacques Boffa, Ziad A. Massy, Bénédicte Stengel, Patrick Rossignol, for the NephroTest Study group

Cael y testun llawn

Renal function can improve at any stage of chronic kidney disease. gan Lise Weis, Marie Metzger, Jean-Philippe Haymann, Eric Thervet, Martin Flamant, François Vrtovsnik, Cédric Gauci, Pascal Houillier, Marc Froissart, Emmanuel Letavernier, Bénédicte Stengel, Jean-Jacques Boffa, NephroTest Study Group

Cael y testun llawn